About
Morningside was founded in 1986 by the Chan family of Hong Kong to make venture capital and private equity investments. The group is characterized by its long-term outlook in company-building and by its unwavering commitment to acting ethically. As pharmaceutical companies invest in expensive therapies often for diseases of very low incidence, Morningside does not shy away from developing affordable therapies for high-prevalence diseases such as tuberculosis, hepatitis B, asthma, autism and dementia. Long before COVID-19, Morningside has been investing in vaccines, the one medical intervention that has saved more lives in human history than any therapeutic has.
Sector Focus
Healthcare
Drug Discovery
Life Sciences
Generative AI
Web3
Blockchain
Data
Series Focus
Seed
Series A
Portfolio
Investment Activity
No timeline data for this period
Score Breakdown
31Deal Activity
24Track Record
0Visibility
10Profile
100Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Morningside Ventures?
Morningside was founded in 1986 by the Chan family of Hong Kong to make venture capital and private equity investments. The group is characterized by its long-term outlook in company-building and by its unwavering commitment to acting ethically. As pharmaceutical companies invest in expensive therapies often for diseases of very low incidence, Morningside does not shy away from developing affordab…
What kind of firm is Morningside Ventures?
Morningside Ventures is a Venture Capital.
Where is Morningside Ventures based?
Morningside Ventures is based in China.
What sectors does Morningside Ventures focus on?
Morningside Ventures focuses on Healthcare, Drug Discovery, Life Sciences, Generative AI.
Similar Investors